APOC3 and metabolic syndrome: Meta-analysis of the 6 multi-ethnic study populations indicated that APOC3 -455C allele carriers had an increased risk of MetS (carrier OR 1.73, 95% CI 1.40 to 2.14, P < 0.0001) (Figure 1).